Schedule 13G ownership disclosure
Soleno Therapeutics Inc
Security class unavailable · CUSIP: 834203309
Event date: 2023-09-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-108315
- Form type
- SC 13G
- Filer
- Fairmount Funds Management LLC
- CIK
- CIK 1802528
- Filed
- Oct 10, 2023
- Reporting period
- Sep 28, 2023
- Description
- Schedule 13G beneficial ownership